We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Healthcare, R&D IT Conference

By Biotechdaily staff writers
Posted on 28 Feb 2006
The accessibility and availability of managed healthcare information and data originating from claims clearinghouses, electronic transaction companies, and electronic medical records (EMR)/electronic healthcare records (EHR) vendors are creating new opportunities to optimize the drug development process. More...
The emerging role of these data sources in clinical research processes will be the focus of the upcoming Drug Information Association's (DIA; Horsham, PA, USA) Research and Development (R&D) Meets Healthcare Information Technology (HIT) conference, March 26-29, 2006, in Philadelphia (PA, USA).

R&D Meets Healthcare IT will provide clinical researchers with the latest information on using emerging databases for site and patient recruitment, obtaining reliable data from claims clearinghouses and EMR/HER vendors, and other pertinent topics from leaders in the private and public sectors as well as from the U.S Food and Drug Administration (FDA). In his keynote address, Dr. Scott Gottlieb, the FDA deputy commissioner for medical and scientific affairs, will discuss the potential of EMR/HER to transform healthcare ad public health initiatives.

This conference is co-sponsored by the Healthcare Information and Management Systems Society (HIMSS; Chicago, IL, USA), and will be held concurrently with DIA's 21st Annual Clinical Data Management Symposium and Exhibition, allowing participants to attend numerous lectures and discussions and examine an expanded exhibit space.

The Drug Information Association serves professionals in the biotechnology, pharmaceutical, and regulatory industries worldwide. Through its U.S. and international meetings, training courses, workshops, and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes.



Related Links:
Drug Information Association

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Urine Chemistry Control
Dropper Urine Chemistry Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Cancer cells (red) stick to mesothelial cells (green) and form hybrid spheres that cut into surrounding abdominal tissue (Photo courtesy of Uno et al., 2026)

Abdominal Fluid Testing Can Predict Ovarian Cancer Progression

Ovarian cancer kills more women than any other gynecological cancer, largely because it is usually diagnosed only after it has spread widely within the abdomen. Unlike many other cancers, it does not rely... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.